Why is Piramal Pharma falling/rising?

As of 29-Jul, Piramal Pharma Ltd's stock is currently priced at 205.65, reflecting an increase of 1.0 (0.49%). The stock has shown a positive movement recently, gaining 1.78% over the last two days despite opening with a loss of 3.84% today. The stock touched an intraday high of Rs 210.35 but also experienced a low of Rs 193.3. In terms of performance against benchmarks, the stock has outperformed the Sensex over the past year with a return of 20.83%, while the Sensex has remained nearly flat at -0.02%. However, it has underperformed its sector today by 0.92%. Positive factors contributing to the stock's recent rise include a healthy long-term growth outlook with an operating profit growth rate of 286.94%, high institutional holdings at 45.12%, and a trading discount compared to peers. Conversely, concerns about the company's ability to service debt, indicated by a high Debt to EBITDA ratio of 3.21 times and a significant drop in PAT, may weigh on investor sentiment.
Broader Market Context: In the short term, Piramal Pharma's stock has shown a slight increase of 0.15% over the past week, while the Sensex has declined by 1.03%. This indicates that the stock is performing relatively better than the broader market in the short term. However, the overall market has faced negative returns, with the BSE500 down by 2.26% over the past year, contrasting with Piramal Pharma's positive return of 20.83%. This suggests that while the stock has been resilient and has attracted investor interest, broader market challenges may still impact its performance moving forward.